LRRC28: A Potential Drug Target and Biomarker (G123355)

Target Name: LRRC28

NCBI ID: G123355

LRRC28

LRRC28: A Potential Drug Target and Biomarker

The long non-coding RNA (lncRNA) landscape has experienced a surge in the identification of potential drug targets and biomarkers. One of these lncRNAs is LRRC28, which has been shown to play a critical role in various biological processes. In this article, we will discuss the potential implications of LRRC28 as a drug target and biomarker.

Understanding LRRC28

LRRC28 is a transcribed RNA molecule that is approximately 28 amino acids long. It is found in various cellular types and has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. LRRC28 is a member of the long non-coding RNA family, which includes molecules that have been implicated in various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

Expression of LRRC28

LRRC28 is expressed in various cellular types, including neurons, endothelial cells, and cancer cells. It has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. LRRC28 has also been shown to play a role in cell survival, as well as the regulation of cell cycle progression.

Potential Drug Target

The potential drug target for LRRC28 is its role in cell adhesion and migration. LRRC28 has been shown to be involved in the regulation of cell-cell adhesion, as well as the regulation of cell migration. LRRC28 has also been shown to play a role in the regulation of the Wnt signaling pathway, which is involved in cell-cell adhesion and migration.

In addition to its role in cell adhesion and migration, LRRC28 has also been shown to play a role in the regulation of cell cycle progression. LRRC28 has been shown to be involved in the regulation of the G1/S transition, as well as the regulation of the G2/M transition.

Potential Biomarker

The potential use of LRRC28 as a biomarker is based on its role in various cellular processes, including cell adhesion, migration, and cell cycle regulation. LRRC28 has been shown to have potential as a biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

LRRC28 has been shown to be involved in the regulation of cancer cell growth and metastasis. For instance, studies have shown that LRRC28 is involved in the regulation of cell proliferation and the development of cancer cell metastases. LRRC28 has also been shown to play a role in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

LRRC28 has also been shown to be involved in the regulation of psychiatric disorders, including depression and anxiety disorders. Studies have shown that LRRC28 is involved in the regulation of neurotransmitter signaling, as well as the regulation of mood and anxiety.

Conclusion

In conclusion, LRRC28 is a transcribed RNA molecule that is involved in various cellular processes, including cell adhesion, migration, and cell cycle regulation. Its potential as a drug target and biomarker is based on its involvement in these processes, as well as its role in the regulation of cancer, neurodegenerative diseases, and psychiatric disorders. Further research is needed to fully understand the potential implications of LRRC28 as a drug target and biomarker.

Protein Name: Leucine Rich Repeat Containing 28

The "LRRC28 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC28 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets